Aspen Pharmacare Debt-Free: Strategic Shift To GLP-1 Injectables

Original Article by Jacob Webster | Business Day | 4 March 2026

Aspen Pharmacare Debt-Free marks a pivotal moment in its history as it shifts focus toward GLP-1 injectables like semaglutide.

Aspen Pharmacare Debt-Free marks a pivotal moment in its history as it shifts focus toward GLP-1 injectables like semaglutide.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Thembisile Xulu Named New Health Director-General

Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.

Read more...

Gauteng Nurse Shortage Deepens, Threatening NHI Rollout

Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.

Read more...

Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options

Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.

Read more...